Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery

Title
Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery
Authors
Keywords
Breast Cancer Patient, Circulate Tumour Cell, Ketorolac, Locoregional Recurrence, Kidney Cancer
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 20, Issue S3, Pages 650-660
Publisher
Springer Nature
Online
2013-07-25
DOI
10.1245/s10434-013-3136-x

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now